NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹227 Cr | ₹216 Cr | ₹311 Cr | ₹340 Cr | ₹351 Cr |
What is the latest Net Current Assets ratio of NECTAR LIFESCIENCES ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹227 Cr |
| Mar2025 | ₹216 Cr |
| Mar2024 | ₹311 Cr |
| Mar2023 | ₹340 Cr |
| Mar2022 | ₹351 Cr |
How is Net Current Assets of NECTAR LIFESCIENCES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹227 Cr | 5.03 | |
| Mar2025 | ₹216 Cr | -30.54 | |
| Mar2024 | ₹311 Cr | -8.59 | |
| Mar2023 | ₹340 Cr | -3.07 | |
| Mar2022 | ₹351 Cr | - | |
Compare Net Current Assets of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹196.8 Cr | -4.2% | -17.6% | -26.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,539.0 Cr | -1.4% | -6.6% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 1.2% | -2.6% | 60% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,251.0 Cr | -2% | -6.1% | 33% | Stock Analytics | |
| CIPLA | ₹105,290.0 Cr | -2.3% | -5.8% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,752.6 Cr | -1.1% | 3.8% | -5.5% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -4.2% |
-17.6% |
-26.5% |
| SENSEX | 0.8% |
-4.8% |
-10.5% |
You may also like the below Video Courses